Novo Nordisk news

The latest news about Novo Nordisk

1. Sep 22 · Biotech GLP-1 drugmakers face lawsuits over alleged sudden vision loss risk 4
2. Sep 9 · Biotech Study links semaglutide to fewer asthma attacks, COPD flare-ups 2
3. Sep 1 · Healthcare channelnewsasia.com: “Oncology firm Novocure says cyberattack exposed US patient records” 2
4. Aug 26 · Cyber Boston Scientific says cybersecurity incident disrupted global order processing, shipping 4
5. Aug 3 · Healthcare 933thedrive.com: “Eli Lilly to offer early access to next - gen obesity drug to some patients” 2
6. Jul 21 · Legal Novo Nordisk sues Eli Lilly over alleged false advertising 5
7. Jul 16 · Healthcare TrumpRx lists 92 brand-name drug deals, under 12% of participating firms' brands 3
8. Jul 6 · Healthcare Wegovy pill becomes available in UK as pharmacies report demand 2
9. Jun 29 · Biotech Medicare to start covering weight-loss drugs on July 1 under pilot 2
10. Jun 27 · Biotech Pfizer's 6.9% dividend yield draws attention as stock trades below pre-pandemic levels 1
11. Jun 23 · Biotech Lexaria says animal study GLP-1-A26-1 began dosing on schedule 2
12. Jun 16 · AI FulcrumSec claims it stole more than a terabyte from Novo Nordisk and sought $25 million 2
13. Jun 15 · Biotech Novo Nordisk discloses IT security incident involving unauthorised access 2
14. Jun 14 · Healthcare Primary care doctors raise alarm as telehealth companies get involved in obesity drugs 7
15. Jun 12 · Biotech leaderlive.co.uk: “Everything to know about the new Wegovy weight loss pill” 3
16. Jun 11 · Healthcare UK regulator approves daily Wegovy pill for weight loss 3
17. Mar 25 · Healthcare argentinastar.com (Big News Network): “India floods market with low - cost versions of weight - loss drugs” 1
18. Mar 24 · Healthcare India warns of misuse risk from weight-loss jabs, reports say 2
19. Mar 23 · Healthcare qz.com: “Alto Neuroscience CFO Nick Smith on firm’s $120 million private placement financing” 1
20. Mar 22 · Healthcare Eli Lilly has submitted orforglipron to the U.S. 1
21. Mar 21 · Healthcare Zydus launches semaglutide injection in reusable multi-dose pen device in India 2
22. Mar 19 · Healthcare Researchers reveal new approach to obesity drug development 6
23. Mar 19 · Healthcare Endpoints News: “Lilly’s triple-G lags Mounjaro on blood sugar lowering, first Phase 3 diabetes data suggest” 1
24. Mar 17 · Legal Delhi HC issues contempt notice to CDSCO over diabetes drug order 2
25. Mar 16 · Healthcare Weight drug boss tells Australia to label unhealthy foods 8
26. Mar 16 · Biotech Reports say parental demand for off-label ASD treatments has increased 17
27. Mar 14 · SaaS Seeking Alpha: “Highest and lowest quant-rated technology stocks above $10B cap after earnings season” 1
28. Mar 12 · Legal Lilly warns of impurity in compounded version of its weight-loss drug 2
29. Mar 12 · Healthcare FDA sends letter to Novo Nordisk over potential GLP-1 side effects 3
30. Mar 10 · Healthcare GLP-1 receptor agonists are being investigated as a treatment for addiction. 4
31. Mar 9 · Healthcare Hims & Hers shares jump on Novo Nordisk GLP-1 deal 2
32. Mar 9 · Healthcare Seeking Alpha: “Evolv Technologies Q4 2025 Earnings Preview” 1
33. Mar 9 · Legal Hims & Hers and Novo Nordisk Settle GLP-1 Litigation, Pivot to Collaboration 7
34. Mar 4 · Healthcare Reports say weight loss boom is reshaping American aesthetics 2
35. Feb 25 · Healthcare US child obesity rates reach record high 1
36. Feb 24 · Healthcare us.cnn.com: “Novo Nordisk to slash Ozempic and Wegovy list prices by up to 50% for 2027” 4

Which desks cover Novo Nordisk?

1. Healthcare 26
2. Biotech 14
3. Legal 4
4. SaaS 1
5. Cyber 1
6. AI 1

Which outlets cover Novo Nordisk most?

1. fool.com 6
2. finance.yahoo.com 4
3. The Star 3
4. gdnonline.com 2
5. koco.com 2
6. Seeking Alpha 2
7. finanznachrichten.de 2
8. wamc.org 2
9. ksmu.org 2
10. wypr.org 2

Counted over the latest 40 events; one per outlet per event. Source: the reports linked on each event.

Who appears in the news with Novo Nordisk?

1. Eli Lilly 23
2. Food and Drug Administration 9
3. Wegovy 7
4. Semaglutide 7
5. Zepbound 6
6. Ozempic 4
7. GLP-1 Receptor Agonists 4
8. MHRA 3
9. Tirzepatide 3
10. Mounjaro 3